UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049664
Receipt number R000056138
Scientific Title A multicenter study of short- and long-term outcomes in operable pancreatic cancer
Date of disclosure of the study information 2022/12/05
Last modified on 2023/12/21 17:51:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter study of short- and long-term outcomes in operable pancreatic cancer

Acronym

A multicenter study of short- and long-term outcomes in operable pancreatic cancer

Scientific Title

A multicenter study of short- and long-term outcomes in operable pancreatic cancer

Scientific Title:Acronym

A multicenter study of short- and long-term outcomes in operable pancreatic cancer

Region

Japan


Condition

Condition

Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective is to identify preoperative factors predictive of poor prognosis and predictive factors for optimal preoperative treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Study 1: To examine biological Borderline Resectable (BR) patients in anatomical Resectable (R) patients of pancreatic cancer
Study 2: Effect of changes in CA19-9 levels after preoperative treatment on recurrence and survival
Study 3: Evaluation of the Usefulness of serum DUPAN-2 for CA19-9 Non-secretors with Pancreatic Cancer
Study 4: An Exploratory study of optimal preoperative treatment for patients with borderline resectable (BR-A) pancreatic cancer
Study 5: An Exploratory study of Risk Factors for Perioperative Complications related to Preoperative Therapy
Study 6: Analysis of the significance of reticular pattern around superior mesenteric artery in computed tomography of R/BR pancreatic cancer and the effect of preoperative Therapy
Study 7: Relationship between ABO blood type and survival outcome after pancreatectomy for pancreatic cancer
Study 8: Significance of metastasectomy in patients with recurrent pancreatic cancer after pancreatectomy

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Pancreatic cancer patients who were diagnosed as R, BR-PV, or BR-A of the resectability classification in the General Rules for the study of Pancreatic cancer (the 7th edition) from Japan pancreatic society.
2. Patients who have not requested refusal by the research subject or by a person who is considered to represent the will and interests of the research subject.
3. 20 years or older.

Key exclusion criteria

1. Patients who do not meet the above inclusion criteria
2. Patients with insufficient clinical data
3. Patients deemed inappropriate as research subjects by the principal investigator

Target sample size

2650


Research contact person

Name of lead principal investigator

1st name Kimitaka
Middle name
Last name Tanaka

Organization

Hokkaido University Hospital

Division name

Department of Gastroenterological surgery 2

Zip code

0608638

Address

Kita-ku North 15 West 7, Sapporo, Hokkaido, Japan

TEL

011-706-7714

Email

kimitaka.t@gmail.com


Public contact

Name of contact person

1st name Kimitaka
Middle name
Last name Tanaka

Organization

Hokkaido University Hospital

Division name

Department of Gastroenterological surgery 2

Zip code

0608638

Address

Kita-ku North 15 West 7, Sapporo, Hokkaido, Japan

TEL

011-706-7714

Homepage URL


Email

kimitaka.t@gmail.com


Sponsor or person

Institute

Department of Gastroenterological surgery 2, Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterological surgery 2, Hokkaido University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital

Address

Kita-ku North 15 West 5, Sapporo, Hokkaido, Japan

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 02 Month 16 Day

Date of IRB

2022 Year 02 Month 16 Day

Anticipated trial start date

2022 Year 07 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective study


Management information

Registered date

2022 Year 12 Month 01 Day

Last modified on

2023 Year 12 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056138


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2024/03/01 240301UMIN.xlsx